Condition
Malignant Mesothelioma
Estimated Enrollment: 68
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: No masking|Primary Purpose: Treatment
Study ID Numbers: CALGB-30901|U10CA180821|U10CA031946|CDR0000667496
Study First Received: March 11, 2010
Last Updated: March 6, 2017
Estimated Primary Completion Date: July 2017
Primary Outcome Measures:
Progression-free survival|Overall survival|Frequency of responses|Toxicity
Sponsors and Collaborators:
Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)
Website Link: https://ClinicalTrials.gov/show/NCT01085630
